AKTX

Akari Therapeutics
AKTX

17 hedge funds and large institutions have $51M invested in Akari Therapeutics in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$529K
2
+$41.5K
3
+$20.7K
4
ACP
Acuta Capital Partners
California
+$20.7K
5
UBS Group
UBS Group
Switzerland
+$10.4K

Top Sellers

1
-$1.77M
2
-$743K
3
-$415K
4
EC
EcoR1 Capital
California
-$114K
5
RCM
RA Capital Management
Massachusetts
-$82.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$16.1M
2
$7.39M
3
$5.54M
4
$5.17M
5
$3.69M
6
$3.21M
7
$2.6M
8
$2.22M
9
$1.96M
10
$1.29M
11
$653K
12
$606K
13
$236K
14
$235K
15
$66K
16
$18K
17
$18K
18
$4K
19
–
20
–
21
–
22
–